Company research / TNBI

Tanke Biosciences Corp (TNBI)

CIK 0001452011 · OTC · Grain Mill Products

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

Not updated since 2012-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

For the year ended 2012-12-31, Tanke Biosciences Corp reported revenue of $28.56M. Revenue grew 19.8% from the prior annual period.

Key ratios (year ended 2012-12-31)

34.8%
Gross margin
15.9%
Operating margin
-0.8%
Net margin
-1.4%
Return on year-end equity
19.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2013-12-26

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.